학술논문

Proposed Biosimilar Gan & Lee Insulin Aspart (GL-ASP) Shows Pharmacokinetic (PK) and Pharmacodynamic (PD) Bioequivalence (BE) to US- and EU-Licensed Insulin Aspart (ASP)
Document Type
Journal
Source
DIABETES; JUN 2021, 70 4p. Supplement: 1
Subject
Language
English
ISSN
1939327X